Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

192 trials

NCT07183423
Recruiting
Novel Skin Barrier Product Versus Petrolatum for Skin Barrier Dysfunction
Not applicable · Philippines · 1 site
Registry update: 19 Sept 2025
NCT07073677
Recruiting
A Study to Evaluate the Efficacy and Safety of IN-115314 Ointment in Mild to Moderate Atopic Dermatitis Adult Patients
Phase 2 · South Korea · 1 site
Registry update: 9 Sept 2026
NCT07239947
Recruiting
A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Moderate to Severe Atopic Dermatitis (AD)
Phase 1 · China · 10 sites
Registry update: 22 Jul 2026
NCT07042126
Recruiting
Evaluation of 611 in Chinese Adolescents With Moderate to Severe Atopic Dermatitis
Phase 3 · China · 3 sites
Registry update: 18 Nov 2025
NCT07021495
Recruiting
SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)
Not applicable · Netherlands · 8 sites
Registry update: 19 Aug 2025
NCT06807268
Recruiting
A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
Phase 3 · China, Germany, Spain, Hungary, Japan, Mexico, Poland, United States · 45 sites
Registry update: 25 Sept 2026
Conflicting statuses (not updated in the registry for 1 month)
NCT06988605
Recruiting
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Not applicable · Germany, United Kingdom, United States · 108 sites
Registry update: 13 Mar 2026
NCT07015762
Recruiting
A Study to Evaluate the Safety and Tolerability of Multiple Dose of IBI3002 in Patients With Atopic Dermatitis
Phase 1 · China · 1 site
Registry update: 7 Aug 2025
NCT07355075
Recruiting
A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)
Phase 2/3 · United States · 1 site
Registry update: 4 Sept 2026
NCT06947980
Recruiting
Study of CM512 in Patients With Moderate-to-Severe Atopic Dermatitis
Phase 2 · China · 1 site
Registry update: 17 Aug 2025
NCT07037901
Recruiting
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
Phase 2 · Australia, Canada, Czechia, Germany, Spain, Hungary, New Zealand, Poland, United States · 85 sites
Registry update: 12 Aug 2026
NCT06982352
Recruiting
Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis
Phase 1 · Jordan, United States · 3 sites
Registry update: 19 Dec 2025
NCT07056569
Recruiting
Post-Marketing Clinical Follow-Up Trial to Evaluate the Performance and Safety of the Medical Device 047 TD Dermatitis Cream in Adults and Children With Atopic and Contact Dermatitis Symptoms Confirmed by Clinical Parameters
Not applicable · Italy · 3 sites
Registry update: 9 Jul 2025
NCT07807228
Recruiting
Changes in Skin Myco- and Microbiome After Lebrikizumab Treatment
Not applicable · Denmark · 1 site
Registry update: 8 Sept 2026
NCT06931990
Recruiting
A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Subjects With Atopic Dermatitis
Phase 1/2 · China · 1 site
Registry update: 27 Aug 2026
NCT06504160
Recruiting
Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)
Phase 1 · United States · 8 sites
Registry update: 2 Jul 2026
NCT06880276
Recruiting
Efficacy and Safety Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis
Phase 3 · China · 1 site
Registry update: 26 Aug 2025
NCT06947993
Recruiting
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
Phase 2 · Argentina, Canada, China, Czechia, Germany, Spain, France, United Kingdom, Hungary, Italy, Japan, South Korea, Netherlands, Poland, Slovakia, Taiwan, United States · 104 sites
Registry update: 28 Sept 2026
NCT07003425
Recruiting
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
Phase 2 · Canada, Czechia, Germany, Spain, France, United Kingdom, Hungary, Poland, United States · 71 sites
Registry update: 3 Nov 2026
NCT06998446
Recruiting
Sodium in the Skin and Atopic Dermatitis
Not applicable · United States · 2 sites
Registry update: 14 Jul 2026

Ordered by registry start date. Freshness and sponsorship never change the order.